OR5P1P

Across TCGA pan-cancer cohorts, OR5P1P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of OR5P1P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR5P1P RNA is repressed in tumor relative to normal tissue. In most cancer types OR5P1P is over-expressed in tumor, although a few such as BRCA and LUAD show the opposite, repressed pattern.

BRCA, LUAD, and LUSC are the cancer types where OR5P1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR5P1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.090	<.001	4	view →
LUAD	Female	II,III,IV	−0.110	.002	2	view →
LUSC	All	All	−0.065	.001	2	view →
ESCA	Female	All	−0.086	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

OR5P1P–BRCA

Open the BRCA breakdown →